Low‐Dose Emicizumab Versus Low‐/Intermediate‐Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding Phenotype

Authors

Institutions

Publication Details

Journal
Haemophilia
Published
2024-12-31
DOI
https://doi.org/10.1111/hae.15146
Citations
9
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
4.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low‐Dose Emicizumab Versus Low‐/Intermediate‐Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding Phenotype

Chonlatis Srichumpuang, Nuttarak Sasipong, Chatphatai Moonla, Itsaraet Gosriwatana et al.
9 citations
Haemophilia
Hemophilia Treatment and Research
4.09
article

Low‐Dose Emicizumab Versus Low‐/Intermediate‐Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding Phenotype

Chonlatis Srichumpuang, Nuttarak Sasipong, Chatphatai Moonla, Itsaraet Gosriwatana, Darintr Sosothikul, Nuchanun Kessakorn
article en
9 citations

Abstract

No abstract available for this paper.
HaemophiliaVol. 31(1)
University of North Carolina at Chapel Hill (US), Chulalongkorn University (TH), King Chulalongkorn Memorial Hospital (TH)
King Chulalongkorn Memorial Hospital, Chulalongkorn University, Faculty of Medicine, Chulalongkorn University
Openalex Percentile: Top 5%
Hemophilia Treatment and Research
4.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.